Page last updated: 2024-10-21

isopentenyl pyrophosphate and HIV Infections

isopentenyl pyrophosphate has been researched along with HIV Infections in 5 studies

isopentenyl pyrophosphate: substrate for isopentenyl pyrophosphate isomerase; RN given refers to unlabeled cpd; a nonpeptide mycobacterial antigen that stimulates gamma delta T cells
isopentenyl diphosphate : A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research Excerpts

ExcerptRelevanceReference
"Peripheral blood mononuclear cells from uninfected controls and HIV+ individuals receiving anti-retroviral therapy were treated with isopentenyl pyrophosphate (IPP) or zoledronate plus IL-2 to expand the Vδ2+ subset."3.78Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. ( Pauza, CD; Poonia, B, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murday, AS1
Chaudhry, S1
Pauza, CD3
Riedel, DJ1
Sajadi, MM1
Armstrong, CL1
Cummings, JS1
Cairo, C1
Redfield, RR1
Poonia, B1
Biswas, P1
Ferrarini, M1
Mantelli, B1
Fortis, C1
Poli, G1
Lazzarin, A1
Manfredi, AA1
Gougeon, ML1
Malkovsky, M1
Casetti, R1
Agrati, C1
Poccia, F1

Reviews

1 review available for isopentenyl pyrophosphate and HIV Infections

ArticleYear
Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
    Vaccine, 2002, May-06, Volume: 20, Issue:15

    Topics: Adjuvants, Immunologic; Antigen Presentation; Antiretroviral Therapy, Highly Active; Chemokines; Dip

2002

Other Studies

4 other studies available for isopentenyl pyrophosphate and HIV Infections

ArticleYear
Interleukin-18 activates Vγ9Vδ2
    Immunology, 2017, Volume: 151, Issue:4

    Topics: Antigens; Cell Proliferation; Cells, Cultured; Diphosphonates; Hemiterpenes; HIV Infections; HIV-1;

2017
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
    AIDS (London, England), 2009, Sep-24, Volume: 23, Issue:15

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD56 Antigen; Cells, Cultured; Cross-Sectional Studies

2009
Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
    Cytotherapy, 2012, Volume: 14, Issue:2

    Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD56 Antigen; Cell Line, Tumor; Diphos

2012
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
    European journal of immunology, 2003, Volume: 33, Issue:1

    Topics: Apoptosis; Cell Division; Cell Line; fas Receptor; Flow Cytometry; Gene Expression Regulation, Viral

2003